CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 85.27%
This Quarter Est. Return
1 Year Est. Return
+85.27%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.52B
AUM Growth
+$30.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
83
New
Increased
Reduced
Closed

Top Buys

1
+$55M
2
+$52.9M
3
+$42.4M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$39.1M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$17.7M

Top Sells

1
+$46.7M
2
+$45.1M
3
+$42.8M
4
VTYX icon
Ventyx Biosciences
VTYX
+$35.4M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$20.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$178M 11.7%
1,655,000
-435,000
2
$147M 9.71%
6,892,101
+827,100
3
$111M 7.29%
3,570,872
+400,000
4
$89.7M 5.91%
1,360,000
-216,872
5
$75.8M 4.99%
8,500,000
+6,163,611
6
$75.6M 4.98%
4,557,414
+3,188,235
7
$49.3M 3.25%
1,600,000
-475,000
8
$42.6M 2.81%
2,800,000
+250,000
9
$42.4M 2.79%
+1,936,133
10
$40.1M 2.64%
2,612,115
-150,000
11
$39.1M 2.58%
+1,700,000
12
$38.4M 2.53%
1,444,000
+661,212
13
$32.5M 2.14%
10,813,246
14
$31.5M 2.07%
44,620
-11,298
15
$29.7M 1.96%
5,150,000
16
$26M 1.71%
2,978,660
17
$23.2M 1.53%
2,386,181
+100,000
18
$22.5M 1.48%
2,893,717
19
$21.6M 1.42%
850,000
-250,000
20
$21.6M 1.42%
2,536,617
21
$19.7M 1.29%
2,946,887
22
$18.5M 1.22%
300,000
-25,000
23
$17.9M 1.18%
1,421,422
-315,000
24
$17.6M 1.16%
322,240
25
$17.5M 1.15%
1,050,000
+350,000
1
2 3 4